Evotec Rises on Boehringer Ingelheim Milestone Payment

Evotec AG rose the most in almost two weeks after saying it received a payment of 1.5 million euros ($1.93 million) for achieving a research milestone under an agreement with Boehringer Ingelheim GmbH.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.